Literature DB >> 12452370

Occurrence of HCC in asymptomatic HCV-related chronic hepatitis.

Marcello Persico1, Bruno Palmentieri, Leonardo Coppola, Giovanni Di Giacomo Russo, Fedele De Marino, Ilario De Sio, Roberto Torella.   

Abstract

Patients with persistently normal ALT affected with HCV-related chronic hepatitis exist. The natural history of liver disease in these patients was demonstrated to be very slow and progression to cirrhosis likely absent. The case we report describes the occurrence of hepatocellular carcinoma (HCC) in a patient with persistently normal ALT affected with mild chronic hepatitis. This observation suggests that asymptomatic carriers of HCV may develop HCC that is not related to underlying liver cirrhosis.

Entities:  

Mesh:

Year:  2002        PMID: 12452370     DOI: 10.1023/a:1020527118782

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

Authors:  A Kasahara; N Hayashi; K Mochizuki; M Takayanagi; K Yoshioka; S Kakumu; A Iijima; A Urushihara; K Kiyosawa; M Okuda; K Hino; K Okita
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

Review 2.  Hepatitis C and hepatocellular carcinoma.

Authors:  A M Di Bisceglie
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

3.  HCV-associated hepatocellular carcinoma without cirrhosis.

Authors:  A el-Refaie; K Savage; S Bhattacharya; S Khakoo; T J Harrison; M el-Batanony; S Nasr; N Mokhtar; K Amer; P J Scheuer; A P Dhillon
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

4.  Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

Authors:  M Persico; E Persico; R Suozzo; S Conte; M De Seta; L Coppola; B Palmentieri; F C Sasso; R Torella
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

5.  Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study.

Authors:  A Sangiovanni; R Morales; G Spinzi; M Rumi; A Casiraghi; R Ceriani; E Colombo; M Fossati; A Prada; E Tavani; G Minoli
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

6.  Hepatocellular carcinoma in Italian patients with cirrhosis.

Authors:  M Colombo; R de Franchis; E Del Ninno; A Sangiovanni; C De Fazio; M Tommasini; M F Donato; A Piva; V Di Carlo; N Dioguardi
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

7.  Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.

Authors:  R B Ray; L M Lagging; K Meyer; R Steele; R Ray
Journal:  Virus Res       Date:  1995-08       Impact factor: 3.303

8.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors:  F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

9.  HCV-associated liver cancer without cirrhosis.

Authors:  M S De Mitri; K Poussin; P Baccarini; P Pontisso; A D'Errico; N Simon; W Grigioni; A Alberti; M Beaugrand; E Pisi
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

10.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.

Authors:  D Sakamuro; T Furukawa; T Takegami
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  3 in total

1.  Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.

Authors:  Kathryn L Nash; Tracy Woodall; Ashley S M Brown; Susan E Davies; Graeme J M Alexander
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Authors:  Roberto Mazzanti; Luca Messerini; Camilla E Comin; Lorenzo Fedeli; Nathalie Ganne-Carrie; Michel Beaugrand
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 3.  Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.

Authors:  Maged Gomaa Hemida; Xin Ye; Simone Thair; Decheng Yang
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.